RYBELSUS 14 MG COM OR CT BL AL AL X 10

Presentation · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brazil

  • Registration number 1176600370099
  • GGREM 526620120009607
  • Barcode 7897705202746

What the source publishes

Holder
NOVO NORDISK FARMACÊUTICA DO BRASIL LTDA
Active ingredients
SEMAGLUTIDA
Package
14 MG COM OR CT BL AL AL X 10
Product type
Biológico
Therapeutic class
A10S - ANTIDIABÉTICOS AGONISTAS DE GLP-1

Names this record is found by

Complete source data
br:cmed:presentations:526620120009607
{
  "name": "RYBELSUS 14 MG COM OR CT BL AL AL X 10",
  "holder": "NOVO NORDISK FARMACÊUTICA DO BRASIL LTDA",
  "stripe": null,
  "barcodes": [
    "7897705202746"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "526620120009607",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "82.277.955/0001-55",
  "priceRegime": "Regulado",
  "productName": "RYBELSUS",
  "productType": "Biológico",
  "hospitalOnly": false,
  "presentation": "14 MG COM OR CT BL AL AL X  10",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "286.92",
    "icms-12": "326.05",
    "icms-17": "345.69",
    "icms-18": "349.90",
    "icms-19": "354.22",
    "icms-20": "358.65",
    "icms-21": "363.19",
    "icms-22": "367.85",
    "icms-23": "372.62",
    "icms-17.5": "347.78",
    "icms-19.5": "356.42",
    "icms-20.5": "360.91",
    "icms-22.5": "370.22",
    "icms-12-alc": "291.11",
    "icms-17-alc": "308.65",
    "icms-18-alc": "312.41",
    "icms-19-alc": "316.27",
    "icms-20-alc": "320.22",
    "icms-21-alc": "324.28",
    "icms-22-alc": "328.43",
    "icms-23-alc": "332.70",
    "withoutTaxes": "256.18",
    "icms-17.5-alc": "310.52",
    "icms-19.5-alc": "318.23",
    "icms-20.5-alc": "322.24",
    "icms-22.5-alc": "330.55"
  },
  "pisCofinsList": "Negativa",
  "substanceText": "SEMAGLUTIDA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "384.89",
    "icms-12": "437.38",
    "icms-17": "463.73",
    "icms-18": "469.38",
    "icms-19": "475.17",
    "icms-20": "481.12",
    "icms-21": "487.21",
    "icms-22": "493.46",
    "icms-23": "499.86",
    "icms-17.5": "466.53",
    "icms-19.5": "478.12",
    "icms-20.5": "484.15",
    "icms-22.5": "496.64",
    "icms-12-alc": "402.44",
    "icms-17-alc": "426.69",
    "icms-18-alc": "431.89",
    "icms-19-alc": "437.22",
    "icms-20-alc": "442.69",
    "icms-21-alc": "448.30",
    "icms-22-alc": "454.04",
    "icms-23-alc": "459.94",
    "withoutTaxes": "354.15",
    "icms-17.5-alc": "429.28",
    "icms-19.5-alc": "439.93",
    "icms-20.5-alc": "445.48",
    "icms-22.5-alc": "456.97"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "SEMAGLUTIDA"
  ],
  "therapeuticClass": "A10S - ANTIDIABÉTICOS AGONISTAS DE GLP-1",
  "commercialisation": {
    "year": 2025,
    "marketed": false
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1176600370099",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "A10S",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:526620120009607"